Literature DB >> 22605803

Multidrug-resistant tuberculosis that required 2 years for diagnosis.

Shuichi Yano1, Kanako Kobayashi, Toshikazu Ikeda.   

Abstract

Isoniazid (H) or rifampicin (R) mono-resistant disease can be treated easily and effectively with first-line drugs, while combined H and R resistance (ie, multidrug-resistant tuberculosis (MDRTB)) requires treatment with at least four agents, including a quinolone and an injectable agent. Drug-resistant Mycobacterium tuberculosis strains are reported to be extremely difficult to cultivate invitro. The authors report a case of MDRTB that required 2 years for diagnosis, and was detected only in sputum culture on solid medium. Physicians should consider MDRTB if TB is suspected but pathogens are not detected.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22605803      PMCID: PMC3316804          DOI: 10.1136/bcr.02.2010.2775

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Utility of CT in the evaluation of pulmonary tuberculosis in patients without AIDS.

Authors:  K S Lee; J W Hwang; M P Chung; H Kim; O J Kwon
Journal:  Chest       Date:  1996-10       Impact factor: 9.410

2.  High resolution computed tomographic findings in pulmonary tuberculosis.

Authors:  O N Hatipoğlu; E Osma; M Manisali; E S Uçan; P Balci; A Akkoçlu; O Akpinar; C Karlikaya; C Yüksel
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

  2 in total
  2 in total

1.  Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice.

Authors:  Hongbo Shen; Feifei Wang; Gucheng Zeng; Ling Shen; Han Cheng; Dan Huang; Richard Wang; Lijun Rong; Zheng W Chen
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

2.  Key Issues in the Management of Multi-Drug Resistant Tuberculosis: A Case Report.

Authors:  Zorica Nanovic; Biserka Kaeva-Jovkovska; Gorica Breskovska; Milena Petrovska
Journal:  Open Access Maced J Med Sci       Date:  2018-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.